Why Amwell’s CEO Isn’t Completely Discouraged By Its Stock Price

Amwell CEO Roy Schoenberg thinks the stock market has adopted a rather simplistic view of telehealth over the past year, reducing the care modality to a pandemic-era trend in which patients are no longer interested. But Schoenberg pointed out that providers are still committed to virtual care. Because of this, he thinks his company is in a better position to raise its stock price than others because it is partnering directly with providers to evolve telehealth delivery models.